当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Publisher Correction: ASPI: a public-private partnership to develop treatments for autism.
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2020-05-06 , DOI: 10.1038/s41573-020-0069-5 Seth Ness 1 , Gahan Pandina 1 , Shyla Jagannatha 1 , Kyle Wathen 2 , Abigail Bangerter 1 , Nikolay V Manyakov 3 , Robert Hendren 4 , Bennett Leventhal 4 , Declan Murphy 5 , Geraldine Dawson 6 , Wayne C Drevets 7 , Husseini K Manji 1
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2020-05-06 , DOI: 10.1038/s41573-020-0069-5 Seth Ness 1 , Gahan Pandina 1 , Shyla Jagannatha 1 , Kyle Wathen 2 , Abigail Bangerter 1 , Nikolay V Manyakov 3 , Robert Hendren 4 , Bennett Leventhal 4 , Declan Murphy 5 , Geraldine Dawson 6 , Wayne C Drevets 7 , Husseini K Manji 1
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译:
出版商更正:ASPI:一种公私合作关系,以开发自闭症的治疗方法。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-05-06
中文翻译:
出版商更正:ASPI:一种公私合作关系,以开发自闭症的治疗方法。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。